Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Trial confirms as-needed inhalers suffice for mild to moderate asthma

Key clinical point: In mild to moderate asthma, as-needed is superior to maintenance inhaled budesonide for preventing severe exacerbations.

Major finding: The per-patient rate of severe exacerbations (0.119 vs. 0.172) was significantly lower (HR 0.69; P = .049) in the as-needed group.

Study details: Multicenter, randomized, open-label trial.

Disclosures: Dr. Hardy reports no potential conflicts of interest.

Citation:

REPORTING FROM ERS 2019